Improve Your Analyses of Large Proteins, Antibodies and Antibody-Drug Conjugates Using Reversed-Phase Liquid Chromatography by Maximizing Pore Access
Bonded Phase: C4
Document Type: White Paper
Market Segment: Biopharmaceuticals
Particle Size: 2.7 µm
Pore Size: 1000 Å
Product Segment: BIOCLASS
Separation Mode: Reversed Phase
USP Number: L26
Download File